Optimi Health Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OPTHF research report →
Price Chart
About the company
Optimi Health Corp. specializes in creating and delivering a comprehensive functional mushroom brand primarily targeting Canada's health and wellness food sector. The company manages the entire value chain for its functional mushroom offerings, from cultivation and extraction to processing and distribution.
- CEO
- Dane Stevens
- IPO
- 2021
- Employees
- 9
- HQ
- Vancouver, BC, CA
Get TickerSpark's AI analysis on OPTHF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $22.76M
- P/E
- -3.42
- PEG
- 0.08
- P/S
- 122.27
- P/B
- 1.62
- EV/EBITDA
- -2.75
- Div Yield
- 0.00%
- Gross Margin
- -2092.20%
- Op Margin
- -3617.97%
- Net Margin
- -3927.59%
- ROE
- -84.23%
- ROIC
- -27.90%
Latest fiscal year · YoY change
- Revenue
- $426.90K+9.5%
- Gross Profit
- $-2,076,619-866.5%
- Op Income
- $-4,534,975
- Net Income
- $-3,717,287.4+38.4%
- EPS
- $-0.04+42.4%
- OCF Growth
- +38.5%
- FCF Growth
- +38.7%
- 52W High
- $0.29
- 52W Low
- $0.10
- 50D MA
- $0.23
- 200D MA
- $0.23
- Beta
- 1.64
- RSI (14)
- 49
- Avg Volume
- 35.77K
No earnings-call transcripts are available for OPTHF yet.
- Free Float
- 77.3%
- Shares Outstanding
- 96.78M
- Float Shares
- 74.78M
Our OPTHF coverage
Recent articles, reports, and earnings notes.
No research on OPTHF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate OPTHF report →Optimi Health Announces Closing of Oversubscribed US$15 Million Public Offering
newsfilecorp.com · May 21
SRx Health Solutions and EMJX Invest in Recent IPO and Commercial-Stage Pharmaceutical Company of Psychedelics, Optimi Health Corp. (OPTH)
globenewswire.com · May 21
Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq Uplisting
newsfilecorp.com · May 20
Optimi Health Files LIFE Offering Document in Connection with NASDAQ Listing
newsfilecorp.com · Apr 23
Optimi Health Launches Ibogaine Initiative as U.S. Executive Order Signals Pathway for Psychedelic Drug Products
newsfilecorp.com · Apr 20
Optimi Health Announces Proposed Nasdaq Listing and U.S. Underwritten Public Offering
newsfilecorp.com · Mar 16
Optimi Health Reports Early Clinical Rollout of Natural Psilocybin Capsules for Treatment-Resistant Depression in Australia
newsfilecorp.com · Feb 26
Optimi Health Completes Psilocybin Export to Australia for Treatment Resistant Depression
newsfilecorp.com · Feb 19
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.